OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, et al.
EMBO Reports (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Antibiotics in the clinical pipeline as of December 2022
Mark S. Butler, Ian R. Henderson, Robert J. Capon, et al.
The Journal of Antibiotics (2023) Vol. 76, Iss. 8, pp. 431-473
Open Access | Times Cited: 118

Metal/metal oxide nanoparticles: A revolution in the biosynthesis and medical applications
Roberta Anjos de Jesus, Geovânia Cordeiro de Assis, Rodrigo de Oliveira, et al.
Nano-Structures & Nano-Objects (2023) Vol. 37, pp. 101071-101071
Closed Access | Times Cited: 41

The pearl jubilee of microcin J25: thirty years of research on an exceptional lasso peptide
Fernando Baquero, Konstantinos Beis, David J. Craik, et al.
Natural Product Reports (2024) Vol. 41, Iss. 3, pp. 469-511
Closed Access | Times Cited: 18

Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance
Jessica A. Collins, Neil Osheroff
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1097-1115
Open Access | Times Cited: 18

Antibiotic resistance: a global crisis, problems and solutions
Rupesh Aggarwal, Pooja Mahajan, Sameeksha Pandiya, et al.
Critical Reviews in Microbiology (2024) Vol. 50, Iss. 5, pp. 896-921
Closed Access | Times Cited: 16

6,7-Coumarin-heterocyclic hybrids: A comprehensive review of their natural sources, synthetic approaches, and bioactivity
Nameer Mazin Zeki, Yasser Fakri Mustafa
Journal of Molecular Structure (2024) Vol. 1303, pp. 137601-137601
Closed Access | Times Cited: 14

Current developments in antibiotic discovery
Julian D. Hegemann, Joy Birkelbach, Sebastian Walesch, et al.
EMBO Reports (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 36

Aminoglycoside uptake, stress, and potentiation in Gram-negative bacteria: new therapies with old molecules
Manon Lang, André Carvalho, Zeynep Baharoglu, et al.
Microbiology and Molecular Biology Reviews (2023) Vol. 87, Iss. 4
Open Access | Times Cited: 20

A metabolomics pipeline highlights microbial metabolism in bloodstream infections
Jared R. Mayers, Jack Varon, Ruixuan Zhou, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 4095-4112.e21
Open Access | Times Cited: 10

Natural linear coumarin-heterocyclic conjugates: A review of their roles in phytotherapy
Nameer Mazin Zeki, Yasser Fakri Mustafa
Fitoterapia (2024) Vol. 175, pp. 105929-105929
Closed Access | Times Cited: 9

Guiding antibiotics towards their target using bacteriophage proteins
Xinghong Zhao, Xinyi Zhong, Shinong Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7

‘Piloting a framework for analysing the public contributions to R&D: new antibiotics in focus’
Louise Schmidt, O. Sehic, Ursula Theuretzbacher, et al.
Journal of Pharmaceutical Policy and Practice (2025) Vol. 18, Iss. 1
Open Access

Advantages and Challenges of Using Antimicrobial Peptides in Synergism with Antibiotics for Treating Multidrug-Resistant Bacteria
Regina Meneses Gonçalves, Bruna Estéfani Dutra Monges, Karen G. N. Oshiro, et al.
ACS Infectious Diseases (2025)
Open Access

An Overview of Cefiderocol’s Therapeutic Potential and Underlying Resistance Mechanisms
Sara Domingues, Tiago Lima, María José Saavedra, et al.
Life (2023) Vol. 13, Iss. 7, pp. 1427-1427
Open Access | Times Cited: 15

An Overview of the Structure–Activity Relationship in Novel Antimicrobial Thiazoles Clubbed with Various Heterocycles (2017–2023)
Daniel Ungureanu, Brîndușa Tiperciuc, Cristina Nastasă, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 89-89
Open Access | Times Cited: 5

Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes
Xiaoyu Chen, Huilin Zhao, Chuandong Wang, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107160-107160
Closed Access | Times Cited: 4

New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development
Carsten E. Seyfert, Alison V. Müller, Danica J. Walsh, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16330-16341
Open Access | Times Cited: 12

Prevalence and Genetic Characterization of Methicillin-Resistant Staphylococcus aureus Isolated from Pigs in Japan
Michiko Kawanishi, Mari Matsuda, Hitoshi Abo, et al.
Antibiotics (2024) Vol. 13, Iss. 2, pp. 155-155
Open Access | Times Cited: 3

The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG
Sebastian Adam, Franziska Fries, Alexander von Tesmar, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8981-8990
Open Access | Times Cited: 3

Arg-biodynamers as antibiotic potentiators through interacting with Gram-negative outer membrane lipopolysaccharides
Mohamed A. M. Kamal, Justine Bassil, Brigitta Loretz, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114336-114336
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top